Telix Gross Profit from 2010 to 2024

TLX Stock

15.76 0.16 1.03%

Telix Pharmaceuticals Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Telix Pharmaceuticals Limited makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

308.5 M

Current Value

323.9 M

Quarterly Volatility

110.4 M

Credit Downgrade

Yuan Drop

Covid

Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 1.1 M, Depreciation And Amortization of 7.1 M or Interest Expense of 7.1 M, as well as many indicators such as Price To Sales Ratio of 0.41, Days Sales Outstanding of 45.23 or Average Payables of 1.8 M. Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Telix Pharmaceuticals Correlation against competitors.

Latest Telix Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Telix Pharmaceuticals Limited over the last few years. Gross profit is a required income statement account that reflects total revenue of Telix Pharmaceuticals Limited minus its cost of goods sold. It is profit before Telix Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Telix Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Telix Gross Profit Regression Statistics

	Arithmetic Mean	50,561,540
	Geometric Mean	6,321,578
	Coefficient Of Variation	218.43
	Mean Deviation	76,689,664
	Median	2,656,000
	Standard Deviation	110,439,052
	Sample Variance	12196.8T
	Range	321.6M
	R-Value	0.66
	Mean Square Error	7468.5T
	R-Squared	0.43
	Significance	0.01
	Slope	16,220,035
	Total Sum of Squares	170755T

Telix Gross Profit History

	2024	323.9 M
	2023	308.5 M
	2022	94.4 M
	2021	2.4 M

Other Fundumenentals of Telix Pharmaceuticals

Gross Profit Margin

Telix Pharmaceuticals Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Long Term Investments
Total Assets		0.78	0.87	-0.74	-0.78	0.93	0.86	0.95	0.73	0.94	0.81	0.9	0.98	0.95	0.23	0.87	0.91	0.95	-0.64
Total Stockholder Equity	0.78		0.47	-0.82	-0.25	0.5	0.37	0.55	0.37	0.51	1.0	0.61	0.79	0.58	0.67	0.78	0.73	0.58	-0.38
Current Deferred Revenue	0.87	0.47		-0.64	-0.94	0.92	0.9	0.93	0.82	0.93	0.52	0.95	0.84	0.92	-0.04	0.71	0.8	0.92	-0.88
Net Debt	-0.74	-0.82	-0.64		0.5	-0.49	-0.37	-0.57	-0.74	-0.57	-0.82	-0.83	-0.82	-0.68	-0.74	-0.52	-0.53	-0.68	0.57
Retained Earnings	-0.78	-0.25	-0.94	0.5		-0.89	-0.89	-0.9	-0.9	-0.92	-0.3	-0.89	-0.77	-0.92	0.14	-0.49	-0.62	-0.92	0.72
Accounts Payable	0.93	0.5	0.92	-0.49	-0.89		0.99	0.99	0.7	0.99	0.55	0.84	0.87	0.95	-0.14	0.81	0.89	0.95	-0.68
Long Term Debt	0.86	0.37	0.9	-0.37	-0.89	0.99		0.97	0.66	0.97	0.43	0.78	0.79	0.91	-0.29	0.76	0.85	0.91	-0.67
Net Receivables	0.95	0.55	0.93	-0.57	-0.9	0.99	0.97		0.77	1.0	0.6	0.89	0.92	0.98	-0.03	0.79	0.87	0.98	-0.66
Good Will	0.73	0.37	0.82	-0.74	-0.9	0.7	0.66	0.77		0.8	0.41	0.92	0.81	0.87	0.27	0.32	0.44	0.87	-0.58
Total Liab	0.94	0.51	0.93	-0.57	-0.92	0.99	0.97	1.0	0.8		0.56	0.89	0.91	0.98	-0.05	0.75	0.84	0.98	-0.67
Net Invested Capital	0.81	1.0	0.52	-0.82	-0.3	0.55	0.43	0.6	0.41	0.56		0.65	0.82	0.62	0.63	0.81	0.77	0.62	-0.41
Short Long Term Debt	0.9	0.61	0.95	-0.83	-0.89	0.84	0.78	0.89	0.92	0.89	0.65		0.92	0.93	0.26	0.65	0.73	0.93	-0.79
Total Current Assets	0.98	0.79	0.84	-0.82	-0.77	0.87	0.79	0.92	0.81	0.91	0.82	0.92		0.95	0.37	0.77	0.82	0.95	-0.59
Capital Stock	0.95	0.58	0.92	-0.68	-0.92	0.95	0.91	0.98	0.87	0.98	0.62	0.93	0.95		0.11	0.71	0.79	1.0	-0.64
Net Working Capital	0.23	0.67	-0.04	-0.74	0.14	-0.14	-0.29	-0.03	0.27	-0.05	0.63	0.26	0.37	0.11		0.06	0.0	0.11	0.07
Short Term Debt	0.87	0.78	0.71	-0.52	-0.49	0.81	0.76	0.79	0.32	0.75	0.81	0.65	0.77	0.71	0.06		0.99	0.71	-0.63
Intangible Assets	0.91	0.73	0.8	-0.53	-0.62	0.89	0.85	0.87	0.44	0.84	0.77	0.73	0.82	0.79	0.0	0.99		0.79	-0.69
Common Stock	0.95	0.58	0.92	-0.68	-0.92	0.95	0.91	0.98	0.87	0.98	0.62	0.93	0.95	1.0	0.11	0.71	0.79		-0.64
Long Term Investments	-0.64	-0.38	-0.88	0.57	0.72	-0.68	-0.67	-0.66	-0.58	-0.67	-0.41	-0.79	-0.59	-0.64	0.07	-0.63	-0.69	-0.64

Click cells to compare fundamentals

About Telix Pharmaceuticals Financial Statements

Telix Pharmaceuticals investors use historical fundamental indicators, such as Telix Pharmaceuticals' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Telix Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	308.5 M	323.9 M
Gross Profit Margin	0.62	0.65

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC